APO RESEARCH · REPORT
Hematopoietic Stem Cells Transplantation
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Product & engineering
Understand the product.
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Selected research
Market Structure
Global Hematopoietic Stem Cells Transplantation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
Report Includes
Read the full market overview
This report provides an overview of the global Hematopoietic Stem Cells Transplantation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hematopoietic Stem Cells Transplantation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hematopoietic Stem Cells Transplantation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hematopoietic Stem Cells Transplantation market size, projected growth trends, production technologies, key applications, and end-use industries.
Hematopoietic Stem Cells Transplantation Segment by Company
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Hematopoietic Stem Cells Transplantation Segment by Type
Stem Cells Storage
Stem Cells Consumables
Hematopoietic Stem Cells Transplantation Segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
Hematopoietic Stem Cells Transplantation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematopoietic Stem Cells Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hematopoietic Stem Cells Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematopoietic Stem Cells Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hematopoietic Stem Cells Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hematopoietic Stem Cells Transplantation industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells Transplantation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hematopoietic Stem Cells Transplantationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cells Storage
- Stem Cells Consumables
Applications
- Leukemia
- Lymphoproliferative Disorders
- Solid Tumors
- Non-Malignant Disorders
Companies covered
- CBR Systems
- China Cord Blood Corporation
- ViaCord
- Thermo Fisher Scientific
- STEMCELL Technologies
- Vcanbio
- Merck Millipore
- Lonza Group
- CellGenix Technologie Transfer
- ThermoGenesis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Stem Cells Storage
- 1.2.3 Stem Cells Consumables
- 1.3 Market Analysis by Application
- 1.3.1 Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Leukemia
- 1.3.3 Lymphoproliferative Disorders
- 1.3.4 Solid Tumors
- 1.3.5 Non-Malignant Disorders
- 1.4 Global Market Growth Prospects
- 1.5 Global Hematopoietic Stem Cells Transplantation Growth Trends by Region
- 1.5.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Hematopoietic Stem Cells Transplantation Market Size by Region (2021-2026)
- 1.5.3 Hematopoietic Stem Cells Transplantation Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Hematopoietic Stem Cells Transplantation Market Dynamics
- 2.1 Hematopoietic Stem Cells Transplantation Industry Trends
- 2.2 Hematopoietic Stem Cells Transplantation Industry Drivers
- 2.3 Hematopoietic Stem Cells Transplantation Industry Opportunities and Challenges
- 2.4 Hematopoietic Stem Cells Transplantation Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Hematopoietic Stem Cells Transplantation Revenue by Company (2021-2026)
- 3.2 Global Hematopoietic Stem Cells Transplantation Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Hematopoietic Stem Cells Transplantation Key Company Head office and Area Served
- 3.4 Global Hematopoietic Stem Cells Transplantation Company, Product Type & Application
- 3.5 Global Hematopoietic Stem Cells Transplantation Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Hematopoietic Stem Cells Transplantation Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Hematopoietic Stem Cells Transplantation Players Market Share by Revenue in 2025
- 3.6.3 2025 Hematopoietic Stem Cells Transplantation Tier 1, Tier 2, and Tier 3
4 Hematopoietic Stem Cells Transplantation Market by Type
- 4.1 Global Hematopoietic Stem Cells Transplantation Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Hematopoietic Stem Cells Transplantation Market Size by Type (2021-2032)
- 4.3 Global Hematopoietic Stem Cells Transplantation Market Size Share by Type (2021-2032)
5 Hematopoietic Stem Cells Transplantation Market by Application
- 5.1 Global Hematopoietic Stem Cells Transplantation Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2032)
- 5.3 Global Hematopoietic Stem Cells Transplantation Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 CBR Systems
- 6.1.1 CBR Systems Company Information
- 6.1.2 CBR Systems Business Overview
- 6.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.1.5 CBR Systems Recent Developments
- 6.2 China Cord Blood Corporation
- 6.2.1 China Cord Blood Corporation Company Information
- 6.2.2 China Cord Blood Corporation Business Overview
- 6.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.2.5 China Cord Blood Corporation Recent Developments
- 6.3 ViaCord
- 6.3.1 ViaCord Company Information
- 6.3.2 ViaCord Business Overview
- 6.3.3 ViaCord Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.3.5 ViaCord Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 STEMCELL Technologies
- 6.5.1 STEMCELL Technologies Company Information
- 6.5.2 STEMCELL Technologies Business Overview
- 6.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.5.5 STEMCELL Technologies Recent Developments
- 6.6 Vcanbio
- 6.6.1 Vcanbio Company Information
- 6.6.2 Vcanbio Business Overview
- 6.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.6.5 Vcanbio Recent Developments
- 6.7 Merck Millipore
- 6.7.1 Merck Millipore Company Information
- 6.7.2 Merck Millipore Business Overview
- 6.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.7.5 Merck Millipore Recent Developments
- 6.8 Lonza Group
- 6.8.1 Lonza Group Company Information
- 6.8.2 Lonza Group Business Overview
- 6.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.8.5 Lonza Group Recent Developments
- 6.9 CellGenix Technologie Transfer
- 6.9.1 CellGenix Technologie Transfer Company Information
- 6.9.2 CellGenix Technologie Transfer Business Overview
- 6.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.9.5 CellGenix Technologie Transfer Recent Developments
- 6.10 ThermoGenesis
- 6.10.1 ThermoGenesis Company Information
- 6.10.2 ThermoGenesis Business Overview
- 6.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.10.5 ThermoGenesis Recent Developments
7 North America
- 7.1 North America Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 7.2 North America Hematopoietic Stem Cells Transplantation Market Size by Type
- 7.2.1 North America Hematopoietic Stem Cells Transplantation Market Size by Type (2021-2026)
- 7.2.2 North America Hematopoietic Stem Cells Transplantation Market Size by Type (2027-2032)
- 7.2.3 North America Hematopoietic Stem Cells Transplantation Market Share by Type (2021-2032)
- 7.3 North America Hematopoietic Stem Cells Transplantation Market Size by Application
- 7.3.1 North America Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2026)
- 7.3.2 North America Hematopoietic Stem Cells Transplantation Market Size by Application (2027-2032)
- 7.3.3 North America Hematopoietic Stem Cells Transplantation Market Share by Application (2021-2032)
- 7.4 North America Hematopoietic Stem Cells Transplantation Market Size by Country
- 7.4.1 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 7.4.3 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 7.4.4 North America Hematopoietic Stem Cells Transplantation Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 8.2 Europe Hematopoietic Stem Cells Transplantation Market Size by Type
- 8.2.1 Europe Hematopoietic Stem Cells Transplantation Market Size by Type (2021-2026)
- 8.2.2 Europe Hematopoietic Stem Cells Transplantation Market Size by Type (2027-2032)
- 8.2.3 Europe Hematopoietic Stem Cells Transplantation Market Share by Type (2021-2032)
- 8.3 Europe Hematopoietic Stem Cells Transplantation Market Size by Application
- 8.3.1 Europe Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2026)
- 8.3.2 Europe Hematopoietic Stem Cells Transplantation Market Size by Application (2027-2032)
- 8.3.3 Europe Hematopoietic Stem Cells Transplantation Market Share by Application (2021-2032)
- 8.4 Europe Hematopoietic Stem Cells Transplantation Market Size by Country
- 8.4.1 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 8.4.3 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 8.4.4 Europe Hematopoietic Stem Cells Transplantation Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 9.2 China Hematopoietic Stem Cells Transplantation Market Size by Type
- 9.2.1 China Hematopoietic Stem Cells Transplantation Market Size by Type (2021-2026)
- 9.2.2 China Hematopoietic Stem Cells Transplantation Market Size by Type (2027-2032)
- 9.2.3 China Hematopoietic Stem Cells Transplantation Market Share by Type (2021-2032)
- 9.3 China Hematopoietic Stem Cells Transplantation Market Size by Application
- 9.3.1 China Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2026)
- 9.3.2 China Hematopoietic Stem Cells Transplantation Market Size by Application (2027-2032)
- 9.3.3 China Hematopoietic Stem Cells Transplantation Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 10.2 Asia Hematopoietic Stem Cells Transplantation Market Size by Type
- 10.2.1 Asia Hematopoietic Stem Cells Transplantation Market Size by Type (2021-2026)
- 10.2.2 Asia Hematopoietic Stem Cells Transplantation Market Size by Type (2027-2032)
- 10.2.3 Asia Hematopoietic Stem Cells Transplantation Market Share by Type (2021-2032)
- 10.3 Asia Hematopoietic Stem Cells Transplantation Market Size by Application
- 10.3.1 Asia Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2026)
- 10.3.2 Asia Hematopoietic Stem Cells Transplantation Market Size by Application (2027-2032)
- 10.3.3 Asia Hematopoietic Stem Cells Transplantation Market Share by Application (2021-2032)
- 10.4 Asia Hematopoietic Stem Cells Transplantation Market Size by Country
- 10.4.1 Asia Hematopoietic Stem Cells Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 10.4.3 Asia Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 10.4.4 Asia Hematopoietic Stem Cells Transplantation Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Type
- 11.2.1 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Application
- 11.3.1 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country
- 11.4.1 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Hematopoietic Stem Cells Transplantation Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst